ResMed Inc.
RMD
Classifica tra le azioni
#706
ResMed Inc. is a leading global medical technology enterprise engaged in the... ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Prezzo delle azioni
$245.56
Ultima sincronizzazione: 2026-10-20
Capitalizzazione di mercato
$34.54B
Variazione (1 giorno)
2.47%
Variazione (1 anno)
-8.45%
Paese
US
Scambia ResMed Inc. (RMD)
Categoria
Healthcare
Ricavi di ResMed Inc. (RMD)
Ricavi nel Jun 2026 TTM: $5.65B
Secondo gli ultimi rapporti finanziari di ResMed Inc., i ricavi attuali dell'azienda (TTM) sono pari a $5.65B. Nel 2024, l'azienda ha registrato ricavi di $4.69B un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $4.22B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per ResMed Inc. da 2000 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $5.65B | 9.85% |
| 2025 | $5.15B | 9.84% |
| 2024 | $4.69B | 10.95% |
| 2023 | $4.22B | 18.02% |
| 2022 | $3.58B | 11.93% |
| 2021 | $3.20B | 8.11% |
| 2020 | $2.96B | 13.44% |
| 2019 | $2.61B | 11.38% |
| 2018 | $2.34B | 13.23% |
| 2017 | $2.07B | 12.40% |
| 2016 | $1.84B | 9.52% |
| 2015 | $1.68B | 7.97% |
| 2014 | $1.55B | 2.68% |
| 2013 | $1.51B | 10.66% |
| 2012 | $1.37B | 10.08% |
| 2011 | $1.24B | 13.80% |
| 2010 | $1.09B | 18.64% |
| 2009 | $920.74M | 10.22% |
| 2008 | $835.40M | 16.62% |
| 2007 | $716.33M | 18.01% |
| 2006 | $607.00M | 42.65% |
| 2005 | $425.51M | 25.39% |
| 2004 | $339.34M | 24.04% |
| 2003 | $273.57M | 34.05% |
| 2002 | $204.08M | 31.53% |
| 2001 | $155.16M | 34.20% |
| 2000 | $115.62M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $46.59B | 724.01% |
US
|
|
| $35.48B | 527.65% |
IE
|
|
| $25.84B | 357.01% |
US
|
|
| $21.00B | 271.38% |
US
|
|
| - | - |
DE
|
